Prakhar Agrawal
Stock Analyst at Cantor Fitzgerald
(3.16)
# 1,287
Out of 4,479 analysts
31
Total ratings
31.82%
Success rate
7.47%
Average return
Main Sectors:
Top Industries:
10 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GPCR Structure Therapeutics | Reiterates: Overweight | $65 | $38.73 | +67.83% | 7 | Jul 1, 2024 | |
| MDGL Madrigal Pharmaceuticals | Initiates: Neutral | n/a | $271.67 | - | 1 | Jun 28, 2024 | |
| ORIC ORIC Pharmaceuticals | Reiterates: Overweight | n/a | $7.52 | - | 3 | Jun 20, 2024 | |
| AKRO Akero Therapeutics | Reiterates: Overweight | n/a | $22.38 | - | 5 | Jun 20, 2024 | |
| RAPT RAPT Therapeutics | Downgrades: Neutral | n/a | $2.79 | - | 2 | Feb 20, 2024 | |
| MLTX MoonLake Immunotherapeutics | Reiterates: Overweight | $78 | $40.15 | +94.27% | 8 | Nov 8, 2023 | |
| TGTX TG Therapeutics | Reiterates: Overweight | $24 | $18.31 | +31.08% | 2 | Apr 17, 2023 | |
| TCRT Alaunos Therapeutics | Assumes: Overweight | $45 | $0.63 | +7,041.72% | 1 | Jul 15, 2022 | |
| OCUP Ocuphire Pharma | Initiates: Buy | n/a | $1.55 | - | 1 | Mar 29, 2021 | |
| EQ Equillium | Initiates: Buy | n/a | $0.68 | - | 1 | Mar 3, 2021 |
Structure Therapeutics
Jul 1, 2024
Reiterates: Overweight
Price Target: $65
Current: $38.73
Upside: +67.83%
Madrigal Pharmaceuticals
Jun 28, 2024
Initiates: Neutral
Price Target: n/a
Current: $271.67
Upside: -
ORIC Pharmaceuticals
Jun 20, 2024
Reiterates: Overweight
Price Target: n/a
Current: $7.52
Upside: -
Akero Therapeutics
Jun 20, 2024
Reiterates: Overweight
Price Target: n/a
Current: $22.38
Upside: -
RAPT Therapeutics
Feb 20, 2024
Downgrades: Neutral
Price Target: n/a
Current: $2.79
Upside: -
MoonLake Immunotherapeutics
Nov 8, 2023
Reiterates: Overweight
Price Target: $78
Current: $40.15
Upside: +94.27%
TG Therapeutics
Apr 17, 2023
Reiterates: Overweight
Price Target: $24
Current: $18.31
Upside: +31.08%
Alaunos Therapeutics
Jul 15, 2022
Assumes: Overweight
Price Target: $45
Current: $0.63
Upside: +7,041.72%
Ocuphire Pharma
Mar 29, 2021
Initiates: Buy
Price Target: n/a
Current: $1.55
Upside: -
Equillium
Mar 3, 2021
Initiates: Buy
Price Target: n/a
Current: $0.68
Upside: -